Format

Send to

Choose Destination
Leukemia. 2016 Apr;30(4):984-7. doi: 10.1038/leu.2015.215. Epub 2015 Aug 5.

Radioimmunotherapy in relapsed/refractory mantle cell lymphoma patients: final results of a European MCL Network Phase II Trial.

Author information

1
Department of Medicine III, University Hospital Großhadern/LMU, München, Germany.
2
Division of Hematology, Department of Molecular Biotechnologies and Health Sciences, University of Torino, Torino, Italy.
3
Department of Oncology and Hematology, Vivantes Klinikum, Berlin, Germany.
4
Charité University Medicine, Department of Hematology and Oncology, Berlin, Germany.
5
Medical Clinic II, University Hospital, Frankfurt, Germany.
6
Department of Hematology and Oncology, Georg-August Universiität, Göttingen, Germany.
7
Hematology/Oncology, University Medical Center, Freiburg, Germany.
8
III Medical Department, Technische Universität München, Munich, Germany.
9
Biostatistician, Division of Nuclear Medicine, Città della Salute e della Scienza, University of Torino, Torino, Italy.
PMID:
26242461
DOI:
10.1038/leu.2015.215
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center